Albioma SA (ABIO.PA)

FR0000060402 - Common Stock

47.14  +0.04 (+0.08%)

Fundamental Rating

2

ABIO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 21 industry peers in the Independent Power and Renewable Electricity Producers industry. Both the profitability and financial health of ABIO have multiple concerns. While showing a medium growth rate, ABIO is valued expensive at the moment.



2

1. Profitability

1.1 Basic Checks

In the past year ABIO was profitable.
Each year in the past 5 years ABIO has been profitable.
In the past 5 years ABIO always reported a positive cash flow from operatings.

1.2 Ratios

Industry RankSector Rank
ROA 2.71%
ROE 9.81%
ROIC 5.3%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 19.98%
PM (TTM) 8.98%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABIO is creating some value.
The number of shares outstanding for ABIO has been increased compared to 1 year ago.
Compared to 1 year ago, ABIO has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.46, we must say that ABIO is in the distress zone and has some risk of bankruptcy.
ABIO has a Debt/Equity ratio of 1.68. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.68
Debt/FCF N/A
Altman-Z 1.46
ROIC/WACC1.11
WACC4.79%

2.3 Liquidity

A Current Ratio of 1.05 indicates that ABIO should not have too much problems paying its short term obligations.
ABIO has a Quick Ratio of 1.05. This is a bad value and indicates that ABIO is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.75

5

3. Growth

3.1 Past

ABIO shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.36%.
Measured over the past years, ABIO shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.59% on average per year.
Looking at the last year, ABIO shows a very strong growth in Revenue. The Revenue has grown by 21.04%.
The Revenue has been growing by 9.28% on average over the past years. This is quite good.
EPS 1Y (TTM)4.36%
EPS 3Y8.34%
EPS 5Y10.59%
EPS growth Q2Q-11.09%
Revenue 1Y (TTM)21.04%
Revenue growth 3Y10.21%
Revenue growth 5Y9.28%
Revenue growth Q2Q22.65%

3.2 Future

Based on estimates for the next years, ABIO will show a small growth in Earnings Per Share. The EPS will grow by 7.39% on average per year.
ABIO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.22% yearly.
EPS Next Y4%
EPS Next 2Y10.38%
EPS Next 3Y7.07%
EPS Next 5Y7.39%
Revenue Next Year8.28%
Revenue Next 2Y6.4%
Revenue Next 3Y6.91%
Revenue Next 5Y6.22%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 26.94, which means the current valuation is very expensive for ABIO.
Compared to an average S&P500 Price/Earnings ratio of 25.20, ABIO is valued at the same level.
A Price/Forward Earnings ratio of 21.36 indicates a rather expensive valuation of ABIO.
ABIO's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.63.
Industry RankSector Rank
PE 26.94
Fwd PE 21.36

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.89

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABIO does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)6.74
PEG (5Y)2.54
EPS Next 2Y10.38%
EPS Next 3Y7.07%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.78%, ABIO has a reasonable but not impressive dividend return.
Compared to the average S&P500 Dividend Yield of 2.44, ABIO is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.78%

5.2 History

The dividend of ABIO is nicely growing with an annual growth rate of 8.92%!
Dividend Growth(5Y)8.92%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

The dividend of ABIO is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DPN/A
EPS Next 2Y10.38%
EPS Next 3Y7.07%

Albioma SA

EPA:ABIO (9/13/2022, 7:00:00 PM)

47.14

+0.04 (+0.08%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.52B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.78%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 26.94
Fwd PE 21.36
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)6.74
PEG (5Y)2.54
Profitability
Industry RankSector Rank
ROA 2.71%
ROE 9.81%
ROCE
ROIC
ROICexc
ROICexgc
OM 19.98%
PM (TTM) 8.98%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 1.68
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.05
Quick Ratio 0.75
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)4.36%
EPS 3Y8.34%
EPS 5Y
EPS growth Q2Q
EPS Next Y4%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)21.04%
Revenue growth 3Y10.21%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y